about
Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study.Persistence of CTL clones targeting melanocyte differentiation antigens was insufficient to mediate significant melanoma regression in humans.Tumor-Specific Effector CD8+ T Cells That Can Establish Immunological Memory in Humans after Adoptive Transfer Are Marked by Expression of IL7 Receptor and c-mycClinical Scale Zinc Finger Nuclease-mediated Gene Editing of PD-1 in Tumor Infiltrating Lymphocytes for the Treatment of Metastatic Melanoma.Identification of an Immunogenic Subset of Metastatic Uveal Melanoma.CTLA4 expression is an indicator and regulator of steady-state CD4+ FoxP3+ T cell homeostasisThe stoichiometric production of IL-2 and IFN-γ mRNA defines memory T cells that can self-renew after adoptive transfer in humans.TLR2 engagement on dendritic cells promotes high frequency effector and memory CD4 T cell responses.T cell receptor-based cancer immunotherapy: Emerging efficacy and pathways of resistanceTOX is a critical regulator of tumour-specific T cell differentiation
P50
Q33440852-DD0F55E5-0966-4464-8E4D-38F4CD987EB5Q35044333-388F3C0F-C88A-4FA1-9047-D7FDC76EAB60Q35958174-D4F810A7-DC9F-4C67-80C3-B2CDE450E652Q36757025-674B755A-5C96-46B1-B697-37289E50956BQ36863359-FC2792BC-8A15-4D65-ACCD-45ED6979457BQ37196273-69CB95CB-EC75-43CB-9848-88FB6DEEE801Q50940546-954C5786-7527-4297-BCEE-F3C1E5A79E88Q51888854-AEBEC083-23CE-4B4F-A044-743EFDE498E8Q92245345-459F6A6D-4A1E-40F7-BECA-F887519885ACQ92812691-0388A869-B018-4F38-AF21-9A84549E70C3
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Smita S Chandran
@en
Smita S Chandran
@nl
type
label
Smita S Chandran
@en
Smita S Chandran
@nl
prefLabel
Smita S Chandran
@en
Smita S Chandran
@nl
P31
P496
0000-0001-9266-6878